Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | NAAA | Q02083 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | PPM1B | O75688 | 1/20 | 0.32 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.32 |
| ▸ | PPP1CC | P36873 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | CES2 | O00748 | 1/20 | 0.31 |
| ▸ | CES1 | P23141 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.31 |
| ▸ | ADH1A | P07327 | 1/20 | 0.30 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.30 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.30 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2515136 | 0.91 | NAAA (0.38) | ALDH1A1NAAASMN1; SMN2MEN1KMT2A | |
| SCHEMBL2523174 | 0.89 | ALDH1A1 (0.41) | ALDH1A1NAAASMN1; SMN2PPM1BPTPN1 | |
| SCHEMBL1131547 | 0.80 | NAAA (0.44) | ALDH1A1NAAASMN1; SMN2MEN1KMT2A | |
| SCHEMBL2518599 | 0.79 | NAAA (0.42) | ALDH1A1NAAASMN1; SMN2MEN1KMT2A | |
| SCHEMBL28656830 | 0.78 | NAAA (0.49) | ALDH1A1NAAACES2 | |
| SCHEMBL28701719 | 0.76 | ALDH1A1 (0.49) | ALDH1A1NAAASMN1; SMN2MEN1KMT2A | |
| SCHEMBL11969563 | 0.74 | SMN1; SMN2 (0.35) | ALDH1A1SMN1; SMN2MEN1KMT2ACES2 | |
| SCHEMBL20960095 | 0.72 | MAPT (0.38) | ALDH1A1SMN1; SMN2PPM1BPTPN1PPP1CC | |
| SCHEMBL29116791 | 0.72 | ALDH1A1 (0.36) | ALDH1A1SMN1; SMN2MEN1KMT2ACES2 | |
| SCHEMBL148328 | 0.72 | ALDH1A1 (0.53) | ALDH1A1NAAASMN1; SMN2PPM1BPTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9051435-B2 | Silanol condensation catalyst, heat-curable silicone resin composition for sealing photosemiconductors and sealed photosemiconductor using same | THE YOKOHAMA RUBBER CO., LTD. (JP) | 2015-06-09 | — | — | US | disclosed |
| US-20140256539-A1 | SILANOL CONDENSATION CATALYST, HEAT-CURABLE SILICONE RESIN COMPOSITION FOR SEALING PHOTOSEMICONDUCTORS AND SEALED PHOTOSEMICONDUCTOR USING SAME | THE YOKOHAMA RUBBER CO., LTD. (JP) | 2014-09-11 | — | — | US | disclosed |
| US-8772431-B2 | Silanol condensation catalyst, heat-curable silicone resin composition for sealing photosemiconductors and sealed photosemiconductor using same | THE YOKOHAMA RUBBER CO., LTD. (JP) | 2014-07-08 | — | — | US | disclosed |
| US-20110248314-A1 | SILANOL CONDENSATION CATALYST, HEAT-CURABLE SILICONE RESIN COMPOSITION FOR SEALING PHOTOSEMICONDUCTORS AND SEALED PHOTOSEMICONDUCTOR USING SAME | THE YOKOHAMA RUBBER CO., LTD. (JP) | 2011-10-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110248314-A1 | SILANOL CONDENSATION CATALYST, HEAT-CURABLE SILICONE RESIN COMPOSITION FOR SEALING PHOTOSEMICONDUCTORS AND SEALED PHOTOSEMICONDUCTOR USING SAME | ASH2L, RCOR1, SEM1 | ALDH1A1 1732/4885NAAA 4190/4885SMN1; SMN2 3472/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.